Stock Market & Financial Investment News

News Breaks January 3, 2013 07:34 EDT RGEN, PFE Repligen enters into licensing agreement with Pfizer for SMA program Repligen (RGEN) has entered into an exclusive worldwide licensing agreement with Pfizer (PFE) to advance Repligen’s spinal muscular atrophy program, originally in-licensed from Families of SMA. The SMA program includes RG3039, a small molecule drug candidate in clinical development for SMA, as well as backup compounds and enabling technologies. Under the terms of the agreement, Repligen is entitled to receive up to $70M from Pfizer, commencing with an upfront payment of $5M and total potential future milestone payments of up to $65M as well as royalties on any future sales of SMA compounds developed under the agreement. SMA is an orphan neurodegenerative genetic disease that presents early in life. Under the terms of the agreement, Repligen is responsible for completing the first two cohorts of an active Phase 1 trial evaluating RG3039 in healthy volunteers, which it anticipates will occur during the first quarter of 2013. Repligen will also provide certain technology transfer services to Pfizer, who will then assume full responsibility for the SMA program moving forward, including the conduct of any registration trials necessary for product approval. Repligen has previously received U.S. Orphan Drug and Fast Track designations for RG3039 for the treatment of SMA, as well as Orphan Medicinal Product designation in the EU. News For RGEN;PFE From The Last 14 Days Check below for free stories on RGEN;PFE the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 18, 2013 09:38 EDT PFE Active equity option families trading on open Active equity option families trading on open according to Track Data: AAPL NFLX GOOG PFE TSLA MGM June 17, 2013 16:00 EDT PFE Options Update; June 17, 2013 Subscribe for More Information 08:36 EDT PFE InSite Vision to join Merck, Pfizer patent suit against Mylan InSite Vision (INSV) announced that it will join Merck (MRK) and Pfizer (PFE) in filing a patent infringement lawsuit against Mylan Pharmaceuticals (MYL). Mylan recently filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking to market a generic version of AzaSite before expiration of the patents covering AzaSite and its use. AzaSite is marketed by Merck in the U.S. On May 26, 2011, InSite and Merck filed a similar patent infringement lawsuit against Sandoz. A trial date for the Sandoz ANDA suit has been set for July 11, 2013. The companies have agreed that Merck will take the lead in prosecuting both lawsuits. Each company will be responsible for their own legal costs, with InSite assuming a monitoring role, the company said. 07:28 EDT PFE Cambridge Healthtech Institute to host a conference Subscribe for More Information June 14, 2013 16:00 EDT PFE Options Update; June 14, 2013 Subscribe for More Information 06:45 EDT PFE Zoetis volatility elevated into Pfizer split-off Subscribe for More Information June 13, 2013 16:00 EDT PFE Options Update; June 13, 2013 Subscribe for More Information 07:32 EDT PFE European League Against Rheumatism to host annual meeting Subscribe for More Information June 12, 2013 16:02 EDT PFE Options Update; June 12, 2013 Subscribe for More Information 13:31 EDT PFE Mylan could be interested in generic assets split from Pfizer, Bloomberg says 08:28 EDT PFE Teva to pay $1.6B to settle with Pfizer, Nycomed over generic Protonix Subscribe for More Information 08:02 EDT PFE Pfizer wins $2.15B settlement from Teva and Sun for patent infringement Subscribe for More Information June 11, 2013 16:00 EDT PFE Options Update; June 11, 2013 Subscribe for More Information 15:15 EDT PFE Pfizer June volatility at one-year high Subscribe for More Information 07:42 EDT PFE Boston Biotech Conferences to host a conference Subscribe for More Information June 10, 2013 07:40 EDT PFE Leerink's biotech analyst holds analyst/industry conference call on ASCO Subscribe for More Information 07:20 EDT PFE Biomed to host a conference Subscribe for More Information June 4, 2013 07:28 EDT PFE Cambridge Healthtech Institute to host a conference Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.